Modified Bayes technique in sequential clinical trials

O. E. Percus, Jerome Percus

Research output: Contribution to journalArticle

Abstract

We consider the problem of optimizing the treatment of a population by two drugs of unknown efficacy. The success or failure of each treatment is assumed to be known before the next patient arrives to be treated, and the objective is to use the developing information both to select optimally for a given patient and to asymptotically restrict treatment to the better of the two drugs. A straightforward Bayes estimator is first assumed. It is shown by computer simulation, and to some extent algebraically, that this leads to the possibility of "trapping" into treatment by the poorer drug, due to early anomalously poor performance by the better drug. The difficulty is ameliorated by imposing a bias towards success on the input (a priori) distribution of the unknown success probabilities. In fact, the resulting protocol, which is ethical from the point of view of the individual patient, is also superior for the full treated population to a few sampling-plus-stopping-rule techniques against which it is compared.

Original languageEnglish (US)
Pages (from-to)127-134
Number of pages8
JournalComputers in Biology and Medicine
Volume14
Issue number2
DOIs
StatePublished - 1984

Fingerprint

Clinical Trials
Sampling
Computer simulation
Pharmaceutical Preparations
Treatment Failure
Computer Simulation
Population
Therapeutics

Keywords

  • Appropriate sequential trials
  • Bayes estimator
  • Clinical evaluation
  • Drug comparison
  • Ethical testing

ASJC Scopus subject areas

  • Computer Science Applications

Cite this

Modified Bayes technique in sequential clinical trials. / Percus, O. E.; Percus, Jerome.

In: Computers in Biology and Medicine, Vol. 14, No. 2, 1984, p. 127-134.

Research output: Contribution to journalArticle

Percus, O. E. ; Percus, Jerome. / Modified Bayes technique in sequential clinical trials. In: Computers in Biology and Medicine. 1984 ; Vol. 14, No. 2. pp. 127-134.
@article{483a543c1b884fee84c02a4d1d23476a,
title = "Modified Bayes technique in sequential clinical trials",
abstract = "We consider the problem of optimizing the treatment of a population by two drugs of unknown efficacy. The success or failure of each treatment is assumed to be known before the next patient arrives to be treated, and the objective is to use the developing information both to select optimally for a given patient and to asymptotically restrict treatment to the better of the two drugs. A straightforward Bayes estimator is first assumed. It is shown by computer simulation, and to some extent algebraically, that this leads to the possibility of {"}trapping{"} into treatment by the poorer drug, due to early anomalously poor performance by the better drug. The difficulty is ameliorated by imposing a bias towards success on the input (a priori) distribution of the unknown success probabilities. In fact, the resulting protocol, which is ethical from the point of view of the individual patient, is also superior for the full treated population to a few sampling-plus-stopping-rule techniques against which it is compared.",
keywords = "Appropriate sequential trials, Bayes estimator, Clinical evaluation, Drug comparison, Ethical testing",
author = "Percus, {O. E.} and Jerome Percus",
year = "1984",
doi = "10.1016/0010-4825(84)90001-5",
language = "English (US)",
volume = "14",
pages = "127--134",
journal = "Computers in Biology and Medicine",
issn = "0010-4825",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Modified Bayes technique in sequential clinical trials

AU - Percus, O. E.

AU - Percus, Jerome

PY - 1984

Y1 - 1984

N2 - We consider the problem of optimizing the treatment of a population by two drugs of unknown efficacy. The success or failure of each treatment is assumed to be known before the next patient arrives to be treated, and the objective is to use the developing information both to select optimally for a given patient and to asymptotically restrict treatment to the better of the two drugs. A straightforward Bayes estimator is first assumed. It is shown by computer simulation, and to some extent algebraically, that this leads to the possibility of "trapping" into treatment by the poorer drug, due to early anomalously poor performance by the better drug. The difficulty is ameliorated by imposing a bias towards success on the input (a priori) distribution of the unknown success probabilities. In fact, the resulting protocol, which is ethical from the point of view of the individual patient, is also superior for the full treated population to a few sampling-plus-stopping-rule techniques against which it is compared.

AB - We consider the problem of optimizing the treatment of a population by two drugs of unknown efficacy. The success or failure of each treatment is assumed to be known before the next patient arrives to be treated, and the objective is to use the developing information both to select optimally for a given patient and to asymptotically restrict treatment to the better of the two drugs. A straightforward Bayes estimator is first assumed. It is shown by computer simulation, and to some extent algebraically, that this leads to the possibility of "trapping" into treatment by the poorer drug, due to early anomalously poor performance by the better drug. The difficulty is ameliorated by imposing a bias towards success on the input (a priori) distribution of the unknown success probabilities. In fact, the resulting protocol, which is ethical from the point of view of the individual patient, is also superior for the full treated population to a few sampling-plus-stopping-rule techniques against which it is compared.

KW - Appropriate sequential trials

KW - Bayes estimator

KW - Clinical evaluation

KW - Drug comparison

KW - Ethical testing

UR - http://www.scopus.com/inward/record.url?scp=0021286264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021286264&partnerID=8YFLogxK

U2 - 10.1016/0010-4825(84)90001-5

DO - 10.1016/0010-4825(84)90001-5

M3 - Article

VL - 14

SP - 127

EP - 134

JO - Computers in Biology and Medicine

JF - Computers in Biology and Medicine

SN - 0010-4825

IS - 2

ER -